Can artificial intelligency revolutionize drug discovery?

AI and Society 35 (2):501-504 (2020)
  Copy   BIBTEX

Abstract

Artificial intelligency can bring speed and reliability to drug discovery process. It represents an additional intelligence, which in any case can replace the strategic and logic creative insight of the medicinal chemist who remains the architect and molecule master designer. In terms of drug design, artificial intelligency, deep learning machines, and other revolutionary technologies will match with the medicinal chemist’s natural intelligency, but for sure never go beyond. This manuscript tries to assess the impact of the artificial intelligency on drug discovery today.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Artificial Intelligence, Psychology, and the Philosophy of Discovery.Paul Thagard - 1982 - PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1982:166 - 175.
A.I., Scientific discovery and realism.Mario Alai - 2004 - Minds and Machines 14 (1):21-42.
System-problems in Kant.Zelko Loparic - 1988 - Synthese 74 (1):107 - 140.
生命的哲学 ‐后基因时代药物筛选策略与传统中药学理论.Xiao Ming Wang - 2008 - Proceedings of the Xxii World Congress of Philosophy 44:139-142.
Ethical Machines?Ariela Tubert - 2018 - Seattle University Law Review 41 (4).
Drug use as consumer behavior.Gordon Robert Foxall & Valdimar Sigurdsson - 2011 - Behavioral and Brain Sciences 34 (6):313-314.
Drug Proscriptions as Proxy Crimes.Douglas Husak - 2017 - Law and Philosophy 36 (4):345-366.

Analytics

Added to PP
2019-05-01

Downloads
38 (#409,607)

6 months
10 (#251,846)

Historical graph of downloads
How can I increase my downloads?

References found in this work

No references found.

Add more references